348 related articles for article (PubMed ID: 21357259)
1. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer.
Kryczek I; Wu K; Zhao E; Wei S; Vatan L; Szeliga W; Huang E; Greenson J; Chang A; Roliński J; Radwan P; Fang J; Wang G; Zou W
J Immunol; 2011 Apr; 186(7):4388-95. PubMed ID: 21357259
[TBL] [Abstract][Full Text] [Related]
2. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
3. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
[TBL] [Abstract][Full Text] [Related]
4. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
[TBL] [Abstract][Full Text] [Related]
5. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
Hovhannisyan Z; Treatman J; Littman DR; Mayer L
Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
[TBL] [Abstract][Full Text] [Related]
7. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma.
Kryczek I; Wang L; Wu K; Li W; Zhao E; Cui T; Wei S; Liu Y; Wang Y; Vatan L; Szeliga W; Greenson JK; Roliński J; Zgodzinski W; Huang E; Tao K; Wang G; Zou W
Oncoimmunology; 2016 Aug; 5(8):e1105430. PubMed ID: 27622054
[TBL] [Abstract][Full Text] [Related]
9. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells.
Pinchuk IV; Beswick EJ; Saada JI; Boya G; Schmitt D; Raju GS; Brenmoehl J; Rogler G; Reyes VE; Powell DW
Gastroenterology; 2011 Jun; 140(7):2019-30. PubMed ID: 21376048
[TBL] [Abstract][Full Text] [Related]
10. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
[TBL] [Abstract][Full Text] [Related]
11. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells.
Murugaiyan G; Mittal A; Lopez-Diego R; Maier LM; Anderson DE; Weiner HL
J Immunol; 2009 Aug; 183(4):2435-43. PubMed ID: 19625647
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
13. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
[TBL] [Abstract][Full Text] [Related]
14. Suppressive IL-17A
Downs-Canner S; Berkey S; Delgoffe GM; Edwards RP; Curiel T; Odunsi K; Bartlett DL; Obermajer N
Nat Commun; 2017 Mar; 8():14649. PubMed ID: 28290453
[TBL] [Abstract][Full Text] [Related]
15. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
Berntsen A; Brimnes MK; thor Straten P; Svane IM
J Immunother; 2010 May; 33(4):425-34. PubMed ID: 20386464
[TBL] [Abstract][Full Text] [Related]
16. An imbalance in interleukin-17-producing T and Foxp3⁺ regulatory T cells in women with idiopathic recurrent pregnancy loss.
Lee SK; Kim JY; Hur SE; Kim CJ; Na BJ; Lee M; Gilman-Sachs A; Kwak-Kim J
Hum Reprod; 2011 Nov; 26(11):2964-71. PubMed ID: 21926059
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
[TBL] [Abstract][Full Text] [Related]
18. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
[TBL] [Abstract][Full Text] [Related]
19. Retinoic Acid Is Elevated in the Mucosa of Patients With Active Ulcerative Colitis and Displays a Proinflammatory Role by Augmenting IL-17 and IFNγ Production.
Rampal R; Wari N; Singh AK; Das U; Bopanna S; Gupta V; Nayak B; Velapandian T; Kedia S; Kumar D; Awasthi A; Ahuja V
Inflamm Bowel Dis; 2021 Jan; 27(1):74-83. PubMed ID: 32469071
[TBL] [Abstract][Full Text] [Related]
20. CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitis.
Götlind YY; Raghavan S; Bland PW; Hörnquist EH
PLoS One; 2011; 6(9):e25073. PubMed ID: 21966415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
